|
KMID : 1142020190540020153
|
|
Blood Research
2019 Volume.54 No. 2 p.153 ~ p.156
|
|
|
What is the most appropriate regimen for untreated Waldenstrom macroglobulinemia? - An updated analysis of rituximab and half-dose CHOP therapy and cost effectiveness
|
|
Sekiguchi Naohiro
Hamano Airi
Kitagawa Tomoko
Ito Kenichi
Hirano Kazuhiko
Yamada Kazuaki
|
|
|
Abstract
|
|
|
|
|
|
|
KEYWORD
|
|
|
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
|
|